Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -136 | 1,104 | 978 | -808 | 3,144 |
| Depreciation Amortization | 4,567 | 1,286 | 644 | 2,588 | 1,946 |
| Income taxes - deferred | -177 | 186 | 184 | -1,181 | N/A |
| Accounts receivable | 8,065 | 6,813 | 4,933 | 1,065 | 1,759 |
| Accounts payable and accrued liabilities | -1,524 | -1,421 | -731 | -492 | 67 |
| Other Working Capital | -3,551 | -3,694 | -2,924 | 274 | -739 |
| Other Operating Activity | -6,541 | -5,393 | -4,202 | 1,009 | -1,770 |
| Operating Cash Flow | $704 | $-1,119 | $-1,118 | $2,455 | $4,407 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,961 | -1,904 | -1,886 | -6,451 | -1,415 |
| Net Acquisitions | -2,438 | -2,436 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -6,973 | N/A |
| Other Investing Activity | 1,983 | 1,984 | 1,980 | -8,958 | 0 |
| Investing Cash Flow | $-2,416 | $-2,356 | $94 | $-15,409 | $-1,415 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 4,556 | 4,565 |
| Other Financing Activity | 690 | -1,050 | 504 | -2,395 | -1,402 |
| Financing Cash Flow | $690 | $-1,050 | $504 | $2,161 | $3,163 |
| Exchange Rate Effect | 66 | 24 | 0 | 86 | 100 |
| Beginning Cash Position | 16,120 | 16,120 | 16,120 | 26,827 | 26,827 |
| End Cash Position | 15,164 | 11,619 | 15,599 | 16,120 | 33,081 |
| Net Cash Flow | $-956 | $-4,501 | $-521 | $-10,707 | $6,254 |
| Free Cash Flow | |||||
| Operating Cash Flow | 704 | -1,119 | -1,118 | 2,455 | 4,407 |
| Capital Expenditure | -1,961 | -1,904 | -1,886 | -6,451 | -1,415 |
| Free Cash Flow | -1,257 | -3,023 | -3,004 | -3,995 | 2,992 |